YiglaM., NakhoulF., SabagA., TovN., GorevichB., AbassiZ., ReisnerS.A.Pulmonary hypertension in patients with end-stage renal disease. Chest2003; 123(5): 1577–82.
2.
Di LulloL., FioccaliF., PolitoP.Right ventricular diastolic function in dialysis patients could be affected by vascular access. Nephron Clin Pract2011; 118: c258–c262.
3.
BeigiA.A., SadeghiA.M., KhosraviA.R., KaramiM., MasoudpourH.Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure. J Vasc Access2009; 10(3): 160–6.
4.
RichS., SeidlitzM., DodinE.. The short term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest1998; 114: 787.
SitbonO., HumbertM., NunesH.. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension. J Am Coll Cardiol2002; 40: 780.
10.
BenzaR.L., RayburnB.K., TallajJ.A., PamboukianS.V., BourgeR.C.Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension: long-term efficacy and combination with bosentan. Chest2008; 134(1): 139–45.
11.
OlschewskiH., SimonneauG., GalièN., HigenbottamT., NaeijeR., RubinL.J.. Inhaled iloprost for severe pulmonary hypertension. N Eng J Med2002; 347(5): 322–9.
12.
GalièN., HumbertM., VachiéryJ.L., VizzaC.D., KneusslM., ManesA., SitbonO., TorbickiA., DelcroixM., NaeijeR., HoeperM., ChaouatA., MorandS., BesseB., SimonneauG.Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Card2002; 39(9): 1496–502.
13.
GalièN., RubinL.J., HoeperM., JansaP., Al-HitiH., MeyerG.M.B., ChiossiE., Kusic-PajicA., SimonneauG.Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet2008a; 371: 2093–100.
14.
GhofraniH.A., WiedemannR., RoseF., SchermulyR.T., OlschewskiH., WeissmannN., GuntherA., WalmrathD., SeegerW., GrimmingerF.Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet2002b; 360: 895–900.
15.
YiglaM., AbassiZ., ReisnerS.A., NakhoulF.Pulmonary hypertension in hemodialysis patients: an unrecognized threat. Semin Dial2006; 19(5): 353–7.
16.
AbdelwhabS., ElshinnawyS.Pulmonary hypertension in chronic renal failure patients. Am J Nephrol2008; 28(6): 990–7.
17.
YiglaM., FruchterO., AhronsonD., YanayN., ReisnerS.A., LewinM., NakhoulF.Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int2009; 75(9): 969–75.
18.
FruchterO., YiglaM.Predictors of long-term survival in elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. Respirology2008; 13(6): 851–5.
BeigiA.A., SadeghiA.M., KhosraviA.R., KaramiM., MasoudpourH.Effects of the arteriovenous fistula on pulmonary artery pressure and cardiac output in patients with chronic renal failure. J Vasc Access2009; 10(3): 160–6.
21.
Di LulloL., FloccariF., GranataA., FioriniF., D'AmelioA., GoriniA., MalagutiM., PolitoP.Ecocardiografia e funzione ventricolare destra in pazienti affetti da IRC in stadio III NKF. Congresso Nazionale di Nefrologia, Genova, 21–24 Settembre 2011. G Ital Nefrol2011; 28(suppl): S53–S60.
